(CWEN) Clearway Energy C - Overview
Stock: Wind, Solar, Battery, Gas
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 5.87% |
| Yield on Cost 5y | 7.12% |
| Yield CAGR 5y | 7.42% |
| Payout Consistency | 96.7% |
| Payout Ratio | 76.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 31.2% |
| Relative Tail Risk | -11.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.55 |
| Alpha | 46.69 |
| Character TTM | |
|---|---|
| Beta | 0.544 |
| Beta Downside | 0.538 |
| Drawdowns 3y | |
|---|---|
| Max DD | 41.52% |
| CAGR/Max DD | 0.30 |
Description: CWEN Clearway Energy C January 09, 2026
Clearway Energy Inc. (NYSE:CWEN) is a U.S.-based independent power producer that manages a diversified portfolio of about 11.8 GW of generation assets across 26 states, split between a Renewable segment (≈ 9 GW of wind, solar and battery energy storage) and a Flexible Generation segment (≈ 2.8 GW of dispatchable combustion-based plants that provide grid reliability services). The company, formerly NRG Yield, rebranded in August 2018 and operates as a subsidiary of Clearway Energy Group LLC.
Key operating metrics (FY 2023) show a net operating income of roughly $1.1 billion and a weighted-average capacity factor of ≈ 35 % for its renewable fleet, reflecting strong wind and solar yields in high-wind states such as Texas and Iowa. The firm’s growth pipeline includes an estimated 2 GW of contracted solar-plus-storage projects slated for completion by 2026, positioning it to capture rising demand for firm-capacity resources as the U.S. power sector decarbonizes.
Sector-wide drivers that materially affect Clearway’s outlook are the Federal Production Tax Credit (PTC) and Investment Tax Credit (ITC) extensions, which underpin renewable project economics, and the current high-interest-rate environment that raises the cost of debt-financed acquisitions-Clearway’s leverage stands at a net-debt-to-EBITDA of ≈ 4.5×, a level that investors monitor closely. If tax credit policy were to change or interest rates fall sharply, the company’s valuation assumptions would need to be revised.
For a deeper, data-driven dive into CWEN’s risk-adjusted valuation, you might find the analytics on ValueRay worth exploring.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 276.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.04 > 1.0 |
| NWC/Revenue: 27.05% < 20% (prev 28.59%; Δ -1.54% < -1%) |
| CFO/TA 0.04 > 3% & CFO 703.0m > Net Income 276.0m |
| Net Debt (8.97b) to EBITDA (1.05b): 8.51 < 3 |
| Current Ratio: 1.54 > 1.5 & < 3 |
| Outstanding Shares: last quarter (118.0m) vs 12m ago 0.0% < -2% |
| Gross Margin: 63.35% > 18% (prev 0.64%; Δ 6271 % > 0.5%) |
| Asset Turnover: 9.07% > 50% (prev 9.57%; Δ -0.50% > 0%) |
| Interest Coverage Ratio: 0.67 > 6 (EBITDA TTM 1.05b / Interest Expense TTM 320.0m) |
Altman Z'' 0.36
| A: 0.02 (Total Current Assets 1.06b - Total Current Liabilities 687.0m) / Total Assets 16.07b |
| B: 0.02 (Retained Earnings 372.0m / Total Assets 16.07b) |
| C: 0.01 (EBIT TTM 214.0m / Avg Total Assets 15.16b) |
| D: 0.04 (Book Value of Equity 360.0m / Total Liabilities 10.28b) |
| Altman-Z'' Score: 0.36 = B |
Beneish M -2.91
| DSRI: 1.19 (Receivables 238.0m/199.0m, Revenue 1.38b/1.36b) |
| GMI: 1.01 (GM 63.35% / 64.00%) |
| AQI: 0.97 (AQ_t 0.19 / AQ_t-1 0.19) |
| SGI: 1.01 (Revenue 1.38b / 1.36b) |
| TATA: -0.03 (NI 276.0m - CFO 703.0m) / TA 16.07b) |
| Beneish M-Score: -2.91 (Cap -4..+1) = A |
What is the price of CWEN shares?
Over the past week, the price has changed by +6.89%, over one month by +15.07%, over three months by +12.17% and over the past year by +55.93%.
Is CWEN a buy, sell or hold?
- StrongBuy: 3
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CWEN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 41.5 | 7.4% |
| Analysts Target Price | 41.5 | 7.4% |
| ValueRay Target Price | 45.2 | 17% |
CWEN Fundamental Data Overview February 03, 2026
P/E Forward = 47.8469
P/S = 5.3574
P/B = 2.1146
P/EG = 3.4097
Revenue TTM = 1.38b USD
EBIT TTM = 214.0m USD
EBITDA TTM = 1.05b USD
Long Term Debt = 8.08b USD (from longTermDebt, last quarter)
Short Term Debt = 342.0m USD (from shortTermDebt, last quarter)
Debt = 9.22b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.97b USD (from netDebt column, last quarter)
Enterprise Value = 16.33b USD (7.37b + Debt 9.22b - CCE 251.0m)
Interest Coverage Ratio = 0.67 (Ebit TTM 214.0m / Interest Expense TTM 320.0m)
EV/FCF = 37.12x (Enterprise Value 16.33b / FCF TTM 440.0m)
FCF Yield = 2.69% (FCF TTM 440.0m / Enterprise Value 16.33b)
FCF Margin = 32.0% (FCF TTM 440.0m / Revenue TTM 1.38b)
Net Margin = 20.07% (Net Income TTM 276.0m / Revenue TTM 1.38b)
Gross Margin = 63.35% ((Revenue TTM 1.38b - Cost of Revenue TTM 504.0m) / Revenue TTM)
Gross Margin QoQ = 70.16% (prev 66.58%)
Tobins Q-Ratio = 1.02 (Enterprise Value 16.33b / Total Assets 16.07b)
Interest Expense / Debt = 1.06% (Interest Expense 98.0m / Debt 9.22b)
Taxrate = 21.0% (US default 21%)
NOPAT = 169.1m (EBIT 214.0m * (1 - 21.00%))
Current Ratio = 1.54 (Total Current Assets 1.06b / Total Current Liabilities 687.0m)
Debt / Equity = 1.61 (Debt 9.22b / totalStockholderEquity, last quarter 5.71b)
Debt / EBITDA = 8.51 (Net Debt 8.97b / EBITDA 1.05b)
Debt / FCF = 20.38 (Net Debt 8.97b / FCF TTM 440.0m)
Total Stockholder Equity = 2.89b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.82% (Net Income 276.0m / Total Assets 16.07b)
RoE = 9.54% (Net Income TTM 276.0m / Total Stockholder Equity 2.89b)
RoCE = 1.95% (EBIT 214.0m / Capital Employed (Equity 2.89b + L.T.Debt 8.08b))
RoIC = 1.70% (NOPAT 169.1m / Invested Capital 9.96b)
WACC = 3.98% (E(7.37b)/V(16.58b) * Re(7.92%) + D(9.22b)/V(16.58b) * Rd(1.06%) * (1-Tc(0.21)))
Discount Rate = 7.92% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 81.65 | Cagr: 0.43%
[DCF Debug] Terminal Value 86.14% ; FCFF base≈422.4m ; Y1≈414.2m ; Y5≈421.8m
Fair Price DCF = 42.94 (EV 12.61b - Net Debt 8.97b = Equity 3.64b / Shares 84.8m; r=5.90% [WACC]; 5y FCF grow -2.87% → 2.90% )
EPS Correlation: -12.45 | EPS CAGR: 89.54% | SUE: 0.50 | # QB: 0
Revenue Correlation: 34.03 | Revenue CAGR: 8.31% | SUE: N/A | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.28 | Chg30d=+0.000 | Revisions Net=+2 | Analysts=4
EPS next Year (2026-12-31): EPS=0.71 | Chg30d=-0.024 | Revisions Net=+2 | Growth EPS=-62.0% | Growth Revenue=+15.6%